IperionX Shares Continue To Bounce As Titanium Production Ramps Up

IperionX shares (ASX: IPX) have added 3.92% to sit at A$4.24 heading into the close of the session today, as markets responded positively to the company’s latest quarterly update, which confirmed the successful transition of its Virginia manufacturing campus to full 24-hour operations and outlined a clear pathway to commercial-scale titanium production.

The IPX share price gain extends a one-month recovery of 32.4%, offering some relief to investors after a turbulent start to the year that saw the stock plunge from previous highs. Despite the recent bounce, IperionX shares remain 26.6% lower year-to-date, reflecting the volatility that has characterised this high-growth titanium technology play throughout 2026. The stock had experienced a particularly sharp correction in March, when it fell from around A$7.14 to A$4 in just three days, prompting an ASX price query and significant insider buying at depressed levels.

Why Are IPX Shares Higher Today?

The March quarter update delivered several operational milestones that appear to have reassured markets about execution risk. IperionX reported that its Virginia Titanium Manufacturing Campus has exited the commissioning phase and transitioned to full 24/7 production, marking a critical inflection point for the company’s HAMR (Hydrogen Assisted Metallothermic Reduction) titanium powder technology. Production reached approximately 4.2 metric tons in March alone, representing an early-stage annualised run rate equivalent to roughly 50 metric tons per annum.

All powder production systems are now commissioned and operational, with management targeting a run rate of approximately 200 metric tons per annum by the end of 2026. The company’s longer-term ambition remains a scale-up to 1,400 metric tons per annum by mid-2027, supported by the full US$47.1 million in obligated funding from the U.S. Department of Defense’s Industrial Base Analysis and Sustainment (IBAS) program. This government backing has been a cornerstone of the investment thesis, positioning IperionX as a strategic player in reshoring critical titanium supply chains for aerospace and defence applications.

The quarterly report also disclosed a quarter-end cash balance of US$48.2 million, with an additional US$42.1 million in obligated U.S. Government funding available for reimbursement as qualifying capital expenditure is incurred. This financial position provides a meaningful runway for the production ramp, though the company remains pre-revenue in any material sense. Customer receipts during the quarter were described as “early stage,” reflecting the company’s current focus on prototyping and qualification batches rather than large-scale commercial orders.

IperionX has also secured approximately 290 metric tons of titanium scrap from U.S. Government agencies, providing roughly 1.5 years of feedstock supply at the planned full operating capacity of 1,400 metric tons per annum. This scrap allocation addresses a key input risk and supports the economic case for the HAMR process, which is designed to convert lower-cost scrap and lower-grade titanium feedstock into high-purity powder suitable for additive manufacturing and other advanced applications.

Development work on the company’s next-generation continuous HAMR platform, known as GenX, progressed during the quarter. Management aims to use this technology to lift productivity and reduce unit costs as volumes scale. Additional high-capacity pressing and sintering equipment is scheduled for commissioning in the current quarter, addressing bottlenecks in the downstream manufacturing process and supporting higher-volume production of finished titanium parts.

In parallel with the Virginia operations, IperionX continues to advance its Titan critical minerals project in Tennessee, with a Definitive Feasibility Study targeted for completion around mid-2026. The project is designed to supply titanium, rare earth elements and zircon, potentially creating a vertically integrated “mine-to-metal” supply chain. While this adds strategic optionality, it also introduces additional capital requirements and execution complexity at a time when the company’s primary focus remains scaling the Virginia campus.

What Next?

Price Targets

Analyst coverage of IperionX has expanded as the company has gained visibility on U.S. exchanges, with several brokerages initiating coverage in recent months. Published price targets have varied widely, with at least one recent summary citing an average NASDAQ target price in the mid-US$50s, implying substantial upside from current levels. These bullish forecasts typically rest on assumptions of successful execution of the 1,400-metric-ton-per-annum expansion, high utilisation rates, sustained government support and the successful commercialisation of customer relationships over the next two to three years.

From a technical perspective, the recent 32% one-month rally has lifted the stock off its March lows, but resistance around the A$4.50 to A$5.00 level on the ASX may prove challenging given the year-to-date losses and the cautious sentiment that persists among some.

The key near-term catalysts for the stock include the commissioning of the new pressing and sintering equipment in the current quarter, any announcements of customer qualification completions or initial commercial orders, and the mid-year release of the Titan project Definitive Feasibility Study. On the downside, any delays in the production ramp, cost overruns, or weaker-than-expected customer traction could quickly reverse recent gains and test investor patience.

A glance at the 1 year chart shows that longer term holders of IPX shares over the period will be sitting on upside of 29.9%, yet the recent volatility that had seen more than a 60% drawdown from January highs into March has put more than a few on edge. Today’s report is a positive, yet it may take a little more in the coming periods in order to bring back those who are not as comfortable with such whipsaw action.